38178 Federal Register / Vol. 83, No. 150 / Friday, August 3, 2018 / Notices 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or third 

party suppliers have the capacity to 

replace the volume of articles 

potentially subject to the recommended 

exclusion order and/or cease and desist 

orders within a commercially 

reasonable time; and 

(v) explain how the recommended 

exclusion order and/or cease and desist 

orders would impact consumers in the 

United States. 

Written submissions must be filed no 

later than by close of business on 

September 6, 2018. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above and submit 8 true paper 

copies to the Office of the Secretary by 

noon the next day pursuant to section 

210.4(f) of the Commission’s Rules of 

Practice and Procedure (19 CFR 

210.4(f)). Submissions should refer to 

the investigation number (‘‘Inv. No. 

1063’’) in a prominent place on the 

cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, https://www.usitc.gov/ 

secretary/documents/handbook_on_

filing_procedures.pdf). Persons with 

questions regarding filing should 

contact the Secretary ((202) 205–2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. appendix 3; or (ii) by U.S. 

government employees and contract 

personnel, solely for cybersecurity 

purposes (all contract personnel will 

sign appropriate nondisclosure 

agreements). All nonconfidential 

written submissions will be available for 

public inspection at the Office of the 

Secretary and on EDIS. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and in part 210 of the Commission’s 

Rules of Practice and Procedure (19 CFR 

part 210). 

By order of the Commission. 

Issued: July 31, 2018. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2018–16651 Filed 8–2–18; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–929 (Rescission 

Proceeding)] 

Certain Beverage Brewing Capsules, 

Components Thereof, and Products 

Containing the Same; Commission 

Determination To Institute a 

Rescission Proceeding; Temporary 

Rescission of the Remedial Orders; 

Termination of the Proceeding 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has determined to institute 

a rescission proceeding, to temporarily 

rescind a March 17, 2016 limited 

exclusion order and three cease-anddesist orders (‘‘the remedial orders’’), 

and to terminate the rescission 

proceeding. 

FOR FURTHER INFORMATION CONTACT: 

Robert Needham, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

708–5468. Copies of non-confidential 

documents filed in connection with this 

investigation are or will be available for 

inspection during official business 

hours (8:45 a.m. to 5:15 p.m.) in the 

Office of the Secretary, U.S. 

International Trade Commission, 500 E 

Street SW, Washington, DC 20436, 

telephone (202) 205–2000. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server (https://www.usitc.gov). 

The public record for this investigation 

may be viewed on the Commission’s 

electronic docket (EDIS) at https://

edis.usitc.gov. Hearing-impaired 

persons are advised that information on 

this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted the original 

investigation on September 9, 2014, 

based on a complaint filed by Adrian 

Rivera and Adrian Rivera Maynez 

Enterprises, Inc. (collectively, ‘‘ARM’’). 

79 FR 53445–46. The complaint alleged 

that several respondents, including Eko 

Brands, LLC (‘‘Eko’’) Evermuch 

Technology Co., Ltd. and Ever Much 

Company Ltd. (together, ‘‘Evermuch’’), 

violated section 337 of the Tariff Act of 

1930, as amended, 19 U.S.C. 1337, by 

infringing certain claims of U.S. Patent 

No. 8,720,320 (‘‘the ’320 patent’’). Id. 

Eko Brands and Evermuch did not 

respond to the complaint and notice of 

investigation, and were found in 

default. Notice (May 18, 2015). On 

March 17, 2016, the Commission issued 

a limited exclusion order prohibiting 

Eko and Evermuch from importing 

certain beverage brewing capsules, 

components thereof, and products 

containing same that infringed claims 8 

or 19 of the ’320 patent, and also issued 

three cease-and-desist orders against 

Eko and the two Evermuch entities 

prohibiting the sale and distribution 

within the United States of articles that 

infringe claims 8 or 19. 81 FR 15742– 

43. 

On April 2, 2015, Eko filed in district 

court for declaratory relief stating, inter 

alia, that Eko does not infringe certain 

claims of the ’320 patent and that 

certain claims of the ’320 patent are 

invalid. Eko Brands v. Adrian Rivera 

Maynez Enterprises Inc. et al., Case No. 

2:15-cv-00522, Dkt. #1 (W.D. Wash.). On 

June 14, 2018, the district court issued 

an order finding that claims 5, 8, 18, and 

19 of the ’320 patent are invalid as 

obvious. Id. at Dkt. #251. 

On June 28, 2018, Eko petitioned the 

Commission to rescind the March 17, 

2016 remedial orders based on the 

district court’s invalidity judgment. On 

July 9, 2018, ARM filed a response that 

did not dispute Eko’s petition, but 

argued that any rescission be temporary 

pending the resolution of ARM’s appeal 

of the district court invalidity judgment. 

Having considered the petition and 

response, the Commission has 

determined to institute a rescission 

proceeding, and has determined that the 

circumstances warrant temporarily 

rescinding the remedial orders pending 

the appeal of the district court invalidity 

judgment. The rescission proceeding is 

hereby terminated. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in part 


amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 150 / Friday, August 3, 2018 / Notices 38179 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: July 30, 2018. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2018–16611 Filed 8–2–18; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: AMRI 

Rensselaer, Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.33(a) on 

or before October 2, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: 

The Attorney General has delegated 

his authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on June 

25, 2018, AMRI Rensselaer, Inc., 33 

Riverside Avenue, Rensselaer, New 

York 12144 applied to be registered as 

a bulk manufacturer of the following 

basic classes of controlled substances: 

Controlled substance Drug code Schedule 

Marihuana ........................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

Amphetamine ................................................................................................................................................................... 1100 II 

Lisdexamfetamine ............................................................................................................................................................ 1205 II 

Pentobarbital .................................................................................................................................................................... 2270 II 

4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... 8333 II 

Codeine ........................................................................................................................................................................... 9050 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Morphine .......................................................................................................................................................................... 9300 II 

The company plans to manufacture 

bulk controlled substances for use in 

product development and for 

distribution to its customers. 

In reference to drug codes 7360 

(marihuana) and 7370 (THC), the 

company plans to bulk manufacture 

these drugs as synthetics. No other 

activities for these drug codes are 

authorized for this registration. 

Dated: July 23, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16635 Filed 8–2–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the 

Comprehensive Environmental 

Response, Compensation and Liability 

Act 

On July 30, 2018, the Department of 

Justice lodged a proposed consent 

decree with the United States District 

Court for the Central District of 

California in the lawsuit entitled United 

States v. Honeywell International, Inc., 

Civil Action No. 2:18-cv-06556. 

The United States filed this lawsuit 

under the Comprehensive 

Environmental Response, 

Compensation, and Liability Act 

(CERCLA) for the recovery of costs that 

the United States incurred responding 

to releases of hazardous substances at 

Installation Restoration Program (IRP) 

Site 50 at Vandenberg Air Force Base in 

Santa Barbara County, California. The 

consent decree requires the defendant 

Honeywell International, Inc. to pay 

$250,000 to the United States. In return, 

the United States agrees not to sue the 

defendant under sections 106 and 107 of 

CERCLA at IRP Site 50 at Vandenberg 

Air Force Base. 

The publication of this notice opens 

a period for public comment on the 

proposed consent decree. Comments 

should be addressed to the Assistant 

Attorney General, Environment and 

Natural Resources Division, and should 

refer to United States v. Honeywell 

International, Inc., D.J. Ref. No. 90–11– 

3–10477/5. All comments must be 

submitted no later than thirty (30) days 

after the publication date of this notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov. 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 

During the public comment period, 

the proposed consent decree may be 

examined and downloaded at this 

Justice Department website: https://

www.justice.gov/enrd/consent-decrees. 

We will provide a paper copy of the 

proposed consent decree upon written 

request and payment of reproduction 

costs. Please mail your request and 

payment to: Consent Decree Library, 

U.S. DOJ—ENRD, P.O. Box 7611, 

Washington, DC 20044–7611. 

Please enclose a check or money order 

for $5.25 (25 cents per page 


amozie on DSK3GDR082PROD with NOTICES1